FindTrial
Sign In

To establish glycomics diagnostic markers for hematological malignances:a single-center observational clinical study

To establish glycomics diagnostic markers for hematological malignances:a single-center observational clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075344
Enrollment
Unknown
Registered
2023-09-01
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematological malignances

Interventions

Gold Standard:Bone marrow detection/Lymph node biopsy
Index test:glycomics testing platform "Gly-Face"

Sponsors

Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years, no gender limitation; 2. Patients with hematological malignancies included in the ' WHO Classification of Hematopoietic and Lymphoid Tissue Tumors ( 4th Edition, 2016 ) ' ; 3. Signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Lack of treatment compliance; 2. Cases that do not meet the diagnostic criteria for hematological malignancies; 3. Be considered inappropriate by researchers.

Design outcomes

Primary

MeasureTime frame
sensitivity;specificity;accuracy;—

Secondary

MeasureTime frame
Glycomics characteristics;—

Countries

China

Contacts

Public ContactOuyang Jian

Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

oy626@sina.com+86 137 7051 8202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026